| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.29 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |